We are thrilled to announce that Rheaply, a pioneering B2B SaaS company dedicated to transforming the landscape of asset management and promoting the circular economy, has successfully raised $20 million in its latest funding round. This significant influx of capital will enable Rheaply to accelerate product development, enhance its technology platform, and expand its footprint in the market. By facilitating the reuse of assets within organizations, Rheaply helps businesses lower procurement and storage costs, while simultaneously minimizing waste—a crucial step towards a more sustainable future. Our innovative platform empowers organizations to track, manage, and share their underutilized resources, thus fostering a culture of sustainability and efficiency. The funds will be instrumental in further refining our technology, allowing us to introduce advanced features to our users and broaden our outreach to diverse industries. With this latest investment, we remain committed to our mission: to drive a shift towards a circular economy where resource optimization becomes the norm, paving the way for economic resilience and environmental stewardship. We are grateful for the support from our investors who share our vision for a more sustainable and circular world, and we are eager to see how this funding will fuel our growth in the coming years. Together, we can revolutionize the way organizations manage their resources and contribute to a healthier planet.
Rheaply Secures $20 Million in Funding to Revolutionize Asset Management and Circular Economy Practices
Get the full Rheaply company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Anveshan
We are a food-tech startup aiming to provide high quality deeply traceable food products. We leverage technologies based on image processing, spectroscopy, blockchain and IOT to provide the best quality food products made traditionally.
$12.7M Series b
today
Caseway
We are the only enterprise AI form platform that replaces internal R&D and manual workflows by building and maintaining fully integrated automation systems, aligned to your data, your processes, and your long-term success. For document-intensive, compliance-driven organizations in regulated industries like insurance, education, finance, healthcare, and government Compelling reason to buy: Who need AI and automation tailored to their unique forms, workflows, and security environment, without having to shoulder R&D risk or manage AI development internally Product category: Our product is an enterprise document form platform Key benefit: That delivers a fully integrated, continuously improving automation system, built and maintained by experts, without upfront AI build costs Key differentiation: Our product is custom-built for each client’s systems and documents, fully integrated and continuously improved through a long-term partnership model, we maintain, debug, adapt, and align incentives to make it work in the real world.
$1.5M Pre-seed
today
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today